U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805994) titled 'Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment' on Jan. 28.
Brief Summary: This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Staphylococcal Aureus Infection
Microbial Colonization
Pediatric Infection
S. Aureus Colonization
Microbial Transplant
Intervention:
BIOLOGICAL: Nasal Microbiota Transplant (NMT)
nasal microbiota transplant
BIOLOGICAL: Placebo
Placebo sterile swab
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Johns Ho...